Treatment

This report reviews progress made until the end of 2010 in scaling up access to health sector interventions for HIV prevention, treatment, care, and support in low–and middle-income countries.

WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens. Results are used to inform ART programme decision making regarding optimal ART regimens and support evaluation of programme quality with respect to maximizing viral load suppression and minimizing emergence of resistance in people taking ART.

This report describes the achievement of program implementation on HIV/AIDS and STI prevention, care, support and treatment during the year 2011.

The new and updated WHO recommendations are intended to support countries to scale up access to and uptake of cervical cancer screening and treatment with quality modern technologies and thereby improve coverage of both screening and treatment and reduce cervical cancer disease and deaths. This policy brief highlights the key features of the new recommendations on screening and treatment for cervical pre-cancer among women living with HIV, and includes programme considerations for implementation including service delivery, service integration and addressing barriers to access.

This report highlights several challenges faced by people living with HIV in the country across the HIV care continuum. Issues on various facets of HIV care continuum such as access to HIV facilities and psychosocial support are surfaced and discussed. Policy and program recommendations that will help the in development of the national HIV program that is more robust, with or without the threats of COVID-19, are also presented.

This document provides guidance on monitoring and evaluating the implementation of the comprehensive package of interventions to address HIV among key populations: men who have sex with men, people in prisons and other closed settings, people who inject drugs, sex workers and transgender people.

In Việt Nam, 263,000 people are estimated to be living with HIV/AIDS and approximately 150,000 people are diagnosed with cancer each year. It is well documented that pain and suffering are prevalent among people with these and other life-limiting illnesses. To better appreciate and respond to the full spectrum of palliative care needs in Việt Nam, the Therapy Department of the Ministry of Health conducted in summer 2005 a rapid situation analysis (RSA) in five high HIV and cancer prevalence provinces in Việt Nam: Hanoi, Hai Phong, Quang Ninh, HCMC and An Giang.

These guidelines provide new and updated recommendations and good practice statements in the following areas: starting ART, including initiating treatment outside the clinic and support for same-day ART start; frequency of clinical visits and ART refills; measuring adherence; tracing and re-engagement in care for all populations; psychosocial support for adolescents living with HIV; task sharing for diagnostic services; and service integration. This guideline seeks to provide support to Member States, programme managers, health workers and other stakeholders seeking to achieve national and international goals to end the HIV epidemic as a public health threat by 2030.